BioCentury
ARTICLE | Company News

Biovail, sanofi-aventis sales and marketing update

April 13, 2009 7:00 AM UTC

sanofi-aventis' sanofi-aventis U.S. unit launched once-daily Aplenzin bupropion in the U.S. to treat major depressive disorder (MDD) in adults aged 18 and older. The price is undisclosed. The product...